|
Alivus Life Sciences Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
12821.36 Cr.
|
P/BV
|
4.05
|
Book Value (Rs.)
|
257.91
|
|
52 Week High/Low (Rs.)
|
1225/819
|
FV/ML
|
2/1
|
P/E(X)
|
22.71
|
|
Bookclosure
|
01/09/2025
|
EPS (Rs.)
|
45.99
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 751.31 | 654.13 | 631.29 | 628.61 | 564.93 |
| | | | | | |
| Net CashFlow From Operating Activities | 565.41 | 391.52 | 413.52 | 313.40 | 597.59 |
| Net Cash Used In Investing Activities | -570.15 | -615.65 | -116.48 | -154.15 | -122.23 |
| Net Cash Used From Financing Activities | -64.34 | -6.23 | -279.44 | -387.59 | -78.80 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -69.08 | -230.35 | 17.59 | -228.33 | 396.56 |
| Cash And Cash Equivalents Begin of Year | 71.06 | 301.41 | 283.82 | 512.16 | 115.60 |
| Cash And Cash Equivalents End Of Year | 1.98 | 71.06 | 301.41 | 283.82 | 512.16 |